Pharmaceutical compositions comprising the PPAR agonist INT-131 and Nrf2 activators Grant US-11484530-B2 United States of America 01 Nov 2022
Treatment Of Hyperglycemia With Solute Carrier Family 39 Member 5 (SLC39A5) Inhibitors Application US-20200297751-A1 United States of America 24 Sep 2020
Pharmaceutical compositions comprising glitazones and NRF2 activators Grant US-10426763-B2 United States of America 01 Oct 2019